NYC Family Court Drug Tests Are Now Voluntary. They Still Flag Methadone.

The urine test happens in the courthouse, often on the day of a hearing, sometimes before a parent has spoken to a lawyer. Since Monday, it is something a parent in New York City can decline.

The policy that took effect Nov. 2 narrows the on-the-spot drug testing that family courts in four boroughs had been preparing to resume. Under the new rules, a supervised screen during the early stages of a child protective proceeding can be requested only by a lawyer for the child or a lawyer for the parent. The adult accused of abuse or neglect decides whether to comply. Judges and the city's Administration for Children's Services can no longer initiate the test themselves, which is how the practice worked before COVID-19 shut it down.

For a parent stable on methadone or buprenorphine, the relief is real but partial. The screen itself has not changed. According to court documents described by The Imprint, the panels detect alcohol, methamphetamine, cocaine, THC, and the medications widely prescribed to treat opioid use disorder. A mother who has taken methadone every morning for two years will produce the same kind of line as a mother who used heroin on Friday, and the court has to sort out which is which.

What actually changed on Nov. 2

The mechanics are small and specific. Testing is confined to cases where the petition alleges drug or alcohol misuse. Trained court staff supervise the collection, and the staff member matches the parent's expressed gender identity, replacing the court officers who used to stand in the room. Judges are barred from announcing results in front of uninvolved observers. The September memo that set up the revised program also told judges that a parent's refusal to take a voluntary test cannot be used against them, even when substance use is alleged in the underlying neglect case.

A spokesperson for the state Office of Court Administration described the program to The Imprint as voluntary and said it lets parents complete a test "only at their request while already at court," which cuts out a separate trip to a testing site and the childcare problem that comes with it. The spokesperson said the point is to give judges and caseworkers timely information and to reduce adjournments, describing the aim as "safe family preservation, reunification, and greater stability for children."

That framing is the court's. The parents' bar reads the same paragraph differently.

The four boroughs in the memo

The September 2025 memo that started this fight named the Bronx, Kings, New York and Queens family courts. Staten Island was not among them. Nothing in the public record suggests the program has been extended to Richmond County, and the court system has not described how it will decide whether to keep, expand or end the practice after the initial cases work through the calendar. For a parent in the four named boroughs, the request can come at the first appearance, before housing, childcare or a treatment schedule have been discussed in front of a judge.

How a urine cup became a federal lawsuit

On-the-spot testing existed for years before the pandemic, and defense attorneys had been complaining about it for just as long. In September 2025, two ranking judges and two court clerks issued a memo reviving it, writing that the testing would "enhance the court's ability to make timely, informed decisions regarding child welfare and family safety."

In June, The Bronx Defenders sued in the Southern District of New York on behalf of two parents in active child protective cases. The complaint described judges who "regularly coerced parents into testing" and penalized those who refused by removing children or denying visits. One parent's declaration, quoted in court records, put it plainly: "I did not feel as though I had a real option not to test. I took the drug tests because I did not want the family court to assume that I was doing anything wrong."

"When saying 'no' means unlawful separation from your child, that is coercion," Trisha Trigilio, the firm's director of impact litigation, said when the suit was filed.

The rollout stopped. The court system revised the rules, sought feedback from parent defense attorneys and child welfare specialists, and put the changes on the record before a federal judge. The Bronx Defenders then withdrew the case voluntarily. Trigilio said the resulting policy is "significantly different" from what the courts intended to launch in June, and that if it is followed to the letter it would be a significant improvement.

Her qualifier is doing a lot of work. The firm has asked how the program will be monitored and how judges have been trained on it; the Office of Court Administration declined to disclose the training, according to The Imprint. The old memo was also, on paper, voluntary.

The methadone problem the memo didn't fix

Nothing in the new policy changes what the assay looks for. Family court screens are built to catch recent use, not to distinguish a prescribed dose from a bag of dope, and the medications that keep people alive are on the list by design because the court wants to know whether a parent is in treatment. The court's stated safeguard is a one-week window for retesting to guard against false positives.

A retest resolves a lab error. It does not resolve the harder question of what a confirmed positive means.

What a positive result proves, and what it doesn't

A courthouse immunoassay is a screening tool. It flags a class of compounds; if the result is contested, a laboratory can run a more specific confirmation that identifies the actual substance and, in some cases, its concentration. That distinction is the difference between "opioids detected" and "buprenorphine detected at a level consistent with a prescribed dose," and it is the difference a parent needs on the record.

Buprenorphine and methadone are the two medications with the strongest evidence for reducing overdose death in opioid use disorder, and federal health officials treat them as standard care rather than as a sign of active addiction. In a child welfare case, though, a positive result still lands in a report that a judge, a caseworker and a lawyer all read, and the parent has to explain it while standing in a hallway.

What parents in treatment can do before a hearing

Ask who requested the test. Under the current policy it has to be a lawyer for the child or a lawyer for the parent, not a judge or a caseworker acting on their own. You can decline, and the memo says the refusal cannot be held against you.

If you consent, the paperwork matters more than the sample. Bring proof of any prescription, a letter from your opioid treatment program showing your dose and start date, and the name of the clinician who manages it. Ask that the result be recorded with that documentation attached. If a positive comes back for methadone or buprenorphine, ask for the retest inside the one-week window and ask, on the record, how the court will distinguish your prescription from illicit use. Tell your attorney before the hearing, not after.

Advocates are also telling parents to get the request on the record, with the date and the name of the person who asked. The policy's protections depend on people in the room knowing they exist, and a parent who has never seen the September memo will not know to ask.

The hesitation treatment providers keep hearing about

The clinical worry runs in the opposite direction from the courtroom one. Medication for opioid use disorder only works if it is taken, and the strongest predictor of whether someone stays on it is whether the people around them treat it as treatment. A parent who believes a positive screen will cost her a custody case has an obvious reason to stop taking buprenorphine before a hearing, or to never start.

Defense attorneys in the Bronx say that fear is not hypothetical; it is the reason some clients ask about tapering before they ask about anything else. The revised policy removes the coercion around the test itself. It cannot remove the incentive a parent feels to make the test come back clean, whatever that costs clinically.

What isn't settled

The program is new, its monitoring plan is unpublished, and the judges who wanted it in the first place are still on the bench. Trigilio's summary is a fair description of where this stands: the rule changed, and the practice is unproven.

For families in the four boroughs, the test is voluntary now. What the test is taken to mean is still an open question, and the answer will be written case by case, in rooms where a parent has about ten minutes and no letter from a doctor.

Parents who need help understanding their rights in a child protective case can contact The Bronx Defenders or any family defense provider in the city. Anyone seeking treatment for opioid use disorder can call the state's HOPEline at 1-877-8-HOPENY (1-877-846-7369).